Terbogrel

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameTerbogrel
Drug Alias Name特波格雷TerbogrelumBIBV-308BIBV-308-SE
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitorsThromboxane A2 receptor antagonists
TargetsThromboxane A2 synthaseThromboxane A2 receptor
Therapy Area/IndicationsHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive IndicationsHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG